MGI Tech Co., Ltd. (SHA:688114)
China · Delayed Price · Currency is CNY 67.50
+0.80 (1.20%)
At close: Feb 6, 2026
MGI Tech Revenue
MGI Tech had revenue of 755.20M CNY in the quarter ending September 30, 2025, with 14.45% growth. This brings the company's revenue in the last twelve months to 3.01B, up 16.92% year-over-year. In the year 2024, MGI Tech had annual revenue of 3.01B with 3.48% growth.
Revenue (ttm)
3.01B
Revenue Growth
+16.92%
P/S Ratio
9.24
Revenue / Employee
1.16M
Employees
2,604
Market Cap
27.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01B | 101.31M | 3.48% |
| Dec 31, 2023 | 2.91B | -1.32B | -31.19% |
| Dec 31, 2022 | 4.23B | 302.16M | 7.69% |
| Dec 31, 2021 | 3.93B | 1.15B | 41.32% |
| Dec 31, 2020 | 2.78B | 1.69B | 154.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 8.08B |
| Lepu Medical Technology (Beijing) | 6.26B |
| Shenzhen New Industries Biomedical Engineering | 4.55B |
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.70B |
| Double Medical Technology | 2.48B |
| APT Medical | 2.41B |
| Jafron Biomedical | 2.04B |